regadenoson has been researched along with Asystole in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Asif, T; Lee Chuy, K; Malhotra, S | 1 |
| Briegas Morera, D; Estepa Alonso, MJ; MartÃn Clavo, S; Rangel Mayoral, JF | 1 |
| Gandhi, H; Goldberg, Y; Hasani, A; Mustehsan, MH; Rashid, SMI | 1 |
| Abdel-Karim, AA; Bateman, TM; Derbas, LA; Medina, CA; Saeed, IM; Thomas, GS | 1 |
| Cohen, M; Dunn, T; Mooney, D; Rosenblatt, J | 1 |
| Hage, FG | 1 |
| Hage, FG; Iskandrian, AE | 1 |
| Abdallah, MS; Bateman, TM; Kureshi, F | 1 |
| Barron, JT; Grady, EC; Wagner, RH | 1 |
1 review(s) available for regadenoson and Asystole
| Article | Year |
|---|---|
Asystole following Regadenoson administration: Review of literature, risk factors and management.
Topics: Aged, 80 and over; Exercise Test; Female; Heart Arrest; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Risk Factors | 2021 |
8 other study(ies) available for regadenoson and Asystole
| Article | Year |
|---|---|
[Asystole after regadenoson administration to perform a myocardial perfusion imaging test].
Topics: Adenosine A2 Receptor Agonists; Aged; Electrocardiography; Heart Arrest; Humans; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Purines; Pyrazoles | 2017 |
Regadenoson-induced asystole and ischemic EKG changes in the setting of underlying coronary disease.
Topics: Aged; Bradycardia; Cardiology; Coronary Artery Disease; Echocardiography; Heart Arrest; Hemodynamics; Humans; Ischemia; Male; Purines; Pyrazoles | 2020 |
Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment Recommendations.
Topics: Adenosine A2 Receptor Agonists; Aged; Aged, 80 and over; Bradycardia; Female; Heart Arrest; Heart Rate; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Severity of Illness Index | 2019 |
Asystole following regadenoson infusion in stable outpatients.
Topics: Adenosine A2 Receptor Agonists; Aged; Ambulatory Care; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Infusions, Intravenous; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2014 |
Regadenoson for myocardial perfusion imaging: Is it safe?
Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2014 |
Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.
Topics: Adenosine A2 Receptor Agonists; Atropine; Bradycardia; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Hypotension; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents | 2014 |
Regadenoson-induced complete heart block and asystole: A real possibility nuclear laboratories should be aware of.
Topics: Aged; Atrioventricular Block; Heart Arrest; Humans; Male; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2017 |
Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.
Topics: Acetylcysteine; Adenosine A2 Receptor Antagonists; Drug Interactions; Expectorants; Heart Arrest; Humans; Male; Middle Aged; Pulmonary Fibrosis; Purines; Pyrazoles; Radionuclide Imaging | 2011 |